Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,990.00
Bid: 5,000.00
Ask: 5,005.00
Change: 6.00 (0.12%)
Spread: 5.00 (0.10%)
Open: 5,015.00
High: 5,020.00
Low: 4,990.00
Prev. Close: 4,984.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

7 Jun 2018 07:00

RNS Number : 5613Q
Intertek Group PLC
07 June 2018
 

Intertek builds presence in growing UK cyber security and network assurance market with acquisition of NTA Monitor

 

7 JUNE 2018

 

Intertek Group plc ("the Group"), a Total Quality Assurance provider to a range of industries worldwide, is pleased to announce that it has acquired NTA Monitor (NTA), a leading network security and assurance services provider, based in the UK and Malaysia.

 

The cyber security market continues to grow rapidly owing to the growth in connected devices and cloud-based applications, as well as increasing regulation and compliance requirements. The acquisition of NTA will build Intertek's presence in the UK security assurance and certification space, one of the largest cyber security markets in the world, whilst strengthening and enlarging the Group's current footprint in the global network assurance and cyber security certification market.

 

Established in 1996, NTA is a founding member of CHECK and has a strong portfolio of accreditations including CREST, CHECK, PCI ASV and Cyber Essentials. It is a trusted information security partner supporting private and public sector organisations that are working towards certification and cyber security compliance. NTA specialises in the provision of penetration testing, compliance certifications, training and auditing solutions, helping organisations to minimise cyber security risks across their supply chains.

 

NTA employs 48 people across the UK and Malaysia and in 2017 generated revenues of c.£3.2 million.

 

André Lacroix, Chief Executive Officer of Intertek, said: "The demand for cyber security Assurance services will continue to grow rapidly as the regulatory environment intensifies and organisations look to secure their networks. The acquisition of NTA further strengthens Intertek's leading presence and expertise in the global cyber security certification and assurance space. We welcome NTA and its experts to Intertek and look forward to capturing the opportunities ahead whilst delivering a differentiated TQA Value Proposition to customers in this critical and high growth area of security."

 

A video describing how the acquisition of NTA complements Intertek's Total Quality Assurance services, can be viewed at www.intertek.com/investors/

 

 

-ENDS-

 

Contacts

For further information, please contact:

 

Denis Moreau, Investor Relations

Telephone: +44 (0) 20 7396 3415 investor@intertek.com 

 

Jonathon Brill, FTI Consulting

Telephone: +44 (0) 20 3727 1000 intertek@fticonsulting.com

 

 

 

 

 

 

About Intertek

Total Quality. Assured.

Intertek is a leading Total Quality Assurance provider to industries worldwide.

Our network of more than 1,000 laboratories and offices and over 43,000 people in more than 100 countries, delivers innovative and bespoke Assurance, Testing, Inspection and Certification solutions for our customers' operations and supply chains.

Intertek Total Quality Assurance expertise, delivered consistently, with precision, pace and passion, enabling our customers to power ahead safely.

intertek.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQEAKKKEFEPEFF
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.